Q3 2025 · 13F-HR
First Light Asset Management, LLCholdings as filed
Filed 2025-11-14 · accession 0001999371-25-017920
$1.06B
Reported value
41
Positions
2025-09-30
Period end
The Brief · First Light Asset Management, LLC · Q3 2025
AI · grounded in 13F
First Light Asset Management, LLC established a new position in AXGN valued at $103.6M. The fund also initiated new stakes in PFMTUSD for $90.6M and CNTA for $88.2M. Additional new positions include NEO at $76.6M and AMLX at $45.6M. Total assets under management stand at $1.06B across 41 positions.
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 05463X106 | AXGN | AXOGEN INC | $103.6M | 9.76% | 5,805,730 | Common | SOLE |
| 71377E105 | PFMTUSD | PERFORMANT HEALTHCARE INC | $90.6M | 8.54% | 11,718,612 | Common | SOLE |
| 152309100 | CNTA | CENTESSA PHARMACEUTICALS LIMITED | $88.2M | 8.31% | 3,635,816 | Common | SOLE |
| 64049M209 | NEO | NEOGENOMICS INC | $76.6M | 7.22% | 9,927,269 | Common | SOLE |
| 03237H101 | AMLX | AMYLYX PHARMACEUTICALS INC | $45.6M | 4.30% | 3,355,882 | Common | SOLE |
| 22663K107 | CRNX | CRINETICS PHARMACEUTICALS INC | $39.2M | 3.70% | 941,516 | Common | SOLE |
| 42225T107 | HCAT | HEALTH CATALYST INC | $38.3M | 3.61% | 13,436,220 | Common | SOLE |
| 697947109 | PVLA | PALVELLA THERAPEUTICS INC | $33.9M | 3.20% | 541,544 | Common | SOLE |
| 90184D100 | TWST | TWIST BIOSCIENCE CORPORATION | $33.6M | 3.17% | 1,194,883 | Common | SOLE |
| 52635N103 | LENZ | LENZ THERAPEUTICS INC | $32.3M | 3.04% | 693,044 | Common | SOLE |
| 68621F102 | ORGO | ORGANOGENESIS HOLDINGS INC | $31.6M | 2.98% | 7,497,911 | Common | SOLE |
| 04963C209 | ATRC | ATRICURE INC | $31.4M | 2.96% | 890,362 | Common | SOLE |
| 032724106 | ANAB | ANAPTYS BIO INC | $30.3M | 2.86% | 990,161 | Common | SOLE |
| 825704109 | SIBN | SI-BONE INC | $28.2M | 2.66% | 1,917,903 | Common | SOLE |
| 171757206 | CDTX | CIDARA THERAPEUTICS INC | $28.0M | 2.64% | 292,657 | Common | SOLE |
| 450056106 | IRTC | IRHYTHM TECHNOLOGIES | $26.7M | 2.51% | 155,099 | Common | SOLE |
| 602496101 | MDXG | MIMEDX GROUP INC | $25.5M | 2.40% | 3,652,952 | Common | SOLE |
| 28036F105 | EWTX | EDGEWISE THERAPEUTICS INC | $23.0M | 2.16% | 1,414,994 | Common | SOLE |
| 65443P102 | MASS | 908 DEVICES INC | $22.0M | 2.07% | 2,510,496 | Common | SOLE |
| N5749R100 | 2GH | MERUS NV | $21.1M | 1.99% | 224,080 | Common | SOLE |
| 76243J105 | RYTM | RHYTHM PHARMACEUTICALS INC | $18.2M | 1.72% | 180,484 | Common | SOLE |
| 40131M109 | GH | GUARDANT HEALTH | $17.5M | 1.65% | 280,001 | Common | SOLE |
| 759910102 | KRMD | KORU MEDICAL SYSTEMS INC | $17.3M | 1.63% | 4,527,737 | Common | SOLE |
| G31249108 | ESTA | ESTABLISHMENT LABS HOLDINGS | $17.1M | 1.62% | 418,358 | Common | SOLE |
| 000899104 | ADMA | ADMA BIOLOGICS INC | $15.7M | 1.48% | 1,069,233 | Common | SOLE |
| 254604101 | IRON | DISC MEDICINE INC | $15.3M | 1.44% | 231,186 | Common | SOLE |
| 92337R101 | VERA | VERA THERAPEUTICS INC | $14.7M | 1.39% | 507,097 | Common | SOLE |
| 641288105 | NPCE | NEUROPACE INC | $14.0M | 1.32% | 1,360,071 | Common | SOLE |
| 142152107 | CAI | CARIS LIFE SCIENCES INC | $11.9M | 1.12% | 403,924 | Common | SOLE |
| 829214105 | SLP | SIMULATIONS PLUS INC | $11.6M | 1.09% | 767,760 | Common | SOLE |
| 90400D108 | RARE | ULTRAGENYX PHARMACEUTICAL INC | $8.6M | 0.81% | 285,699 | Common | SOLE |
| 00370M103 | ABVX | ABIVAX SA-ADR | $8.1M | 0.77% | 95,955 | Common | SOLE |
| 81727U105 | SENS1GBP | SENSEONICS HOLDINGS INC | $7.8M | 0.74% | 18,007,632 | Common | SOLE |
| 759916109 | RGEN | REPLIGEN CORP | $5.5M | 0.52% | 41,427 | Common | SOLE |
| 86366E106 | GPCR | STRUCTURE THERAPEUTICS INC | $5.5M | 0.52% | 197,350 | Common | SOLE |
| 558868105 | MDGL | MADRIGAL PHARMACEUTICALS INC | $5.3M | 0.50% | 11,539 | Common | SOLE |
| 30050B101 | EVH | EVOLENT HEALTH INC | $4.6M | 0.43% | 545,282 | Common | SOLE |
| 01625V104 | ALHC | ALIGNMENT HEALTHCARE INC | $3.5M | 0.33% | 203,138 | Common | SOLE |
| 750491102 | RDNT | RADNET INC | $3.2M | 0.30% | 42,280 | Common | SOLE |
| 878972108 | TECX | TECTONIC THERAPEUTICS INC | $3.2M | 0.30% | 202,393 | Common | SOLE |
| 124155102 | BFLY | BUTTERFLY NETWORK INC | $2.2M | 0.21% | 1,127,998 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.